Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 27;195(12):E466-E468.
doi: 10.1503/cmaj.221208-f.

Instruments au laser pour rajeunissement vaginal : efficacité, réglementation et commercialisation

[Article in French]
Blayne Welk  1 , Erin Kelly  2
Affiliations

Instruments au laser pour rajeunissement vaginal : efficacité, réglementation et commercialisation

[Article in French]
Blayne Welk et al. CMAJ. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Intérêts concurrents: Blayne Welk déclare avoir reçu des honoraires de consultation de la société Becton, Dickinson and Company, indépendamment des présents travaux et il est vice-président de la Société internationale de neuro-urologie et du Groupe de recherche américain sur la vessie neurogène. Erin Kelly déclare avoir reçu une subvention de recherche de la société Pharmaceutique Searchlight Inc., indépendamment des travaux soumis.

References

    1. The NAMS 2020 GSM Position Statement Editorial Panel. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause 2020;27:976–92. - PubMed
    1. Kingsberg SA, Wysocki S, Magnus L, et al. . Vulvar and vaginal atrophy in post-menopausal women: findings from the REVIVE (REal Women’s VIews of Treatment Options for Menopausal Vaginal ChangEs) survey. J Sex Med 2013;10:1790–9. - PubMed
    1. Lethaby A, Ayeleke RO, Roberts H. Local oestrogen for vaginal atrophy in post-menopausal women. Cochrane Database Syst Rev 2016;2016:CD001500. - PMC - PubMed
    1. Tadir Y, Gaspar A, Lev-Sagie A, et al. . Light and energy based therapeutics for genitourinary syndrome of menopause: consensus and controversies. Lasers Surg Med 2017;49:137–59. - PMC - PubMed
    1. Kaunitz AM, Pinkerton JV, Manson JE. Women harmed by vaginal laser for treatment of GSM: the latest casualties of fear and confusion surrounding hormone therapy. Menopause 2019;26:338–40. - PMC - PubMed

LinkOut - more resources